Artificial Pancreas (AP) at home

Diabetes is taking on epidemic proportions with over 220 million individuals affected worldwide. One third are treated with subcutaneous insulin injection treatment.
AP@home is an European research project funded by the European Commission under the IST framework programme 7 for Information and Communication Technology, ICT.

The main goal of AP@home is to improve treatment of patients with diabetes at home by

1) improving closed-loop algorithms for artificial pancreas

2) build and validate a single-port artificial pancreas providing remote alarms